Pharmacologically regulated gene expression in the retina following transduction with viral vectors
- 1 March 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (6) , 442-446
- https://doi.org/10.1038/sj.gt.3301413
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 23 references indexed in Scilit:
- Gene therapy and retinitis pigmentosa: advances and future challengesBioEssays, 2001
- Gene Therapy for Ocular DiseaseMolecular Therapy, 2000
- Additional Transduction Events after Subretinal Readministration of Recombinant Adeno-Associated VirusHuman Gene Therapy, 2000
- High throughput method for creating and screening recombinant adenovirusesGene Therapy, 1998
- Retinopathy induced in mice by targeted disruption of the rhodopsin geneNature Genetics, 1997
- Ocular toxicity of intravitreous transforming growth factor-beta 1Eye, 1996
- Gene transfer into the mouse retina mediated by an adeno-associated viral vectorHuman Molecular Genetics, 1996
- Transcriptional Activation by Tetracyclines in Mammalian CellsScience, 1995
- Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosaNeuron, 1992
- A Null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosaNature Genetics, 1992